©The Author(s) 2020.
World J Gastrointest Oncol. Aug 15, 2020; 12(8): 850-856
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.850
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.850
Table 3 Types of gastric neuroendocrine tumors
| Type I | Type II | Type III | |
| Prevalence, % | 70-80 | 5-10 | 10-20 |
| Background | Chronic atrophic gastritis | Gastrinomas (Zollinger-Ellison syndrome) | Normal mucosa |
| Other syndromes | Autoimmune polyglandular syndrome | MEN-1 syndrome | |
| Number of lesions | Multiple | Multiple | Single |
| Site of tumor | Fundus/body | Fundus/body | Fundus/body |
| Cell of origin | ECL | ECL | ECL, EC or X cell |
| Serum gastrin levels | Elevated | Elevated | Normal |
| Gastric PH | High | Low | Normal |
| Underlying mucosa | Atrophic | Hypertrophic | Normal |
| Size of tumors, usual | 1-2 cm | 1 cm | > 2 cm |
| Invasion | Rare | More common | Common |
| Metastases | |||
| Lymph nodes | 5%-10% | 10%-20% (duodenal tumors) | 50%-100% |
| Liver | 2%-5% | 10% | 22%-75% |
| Prognosis | Excellent | Very good | Similar to gastric adenocarcinoma |
- Citation: Roberto GA, Rodrigues CMB, Peixoto RD, Younes RN. Gastric neuroendocrine tumor: A practical literature review. World J Gastrointest Oncol 2020; 12(8): 850-856
- URL: https://www.wjgnet.com/1948-5204/full/v12/i8/850.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i8.850